Oncotelic Therapeutics, Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Oncotelic Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was -43.9 %, a 45.7% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Return On Equity for 2023 was -58.5 %, a 312% decline from 2022.
  • Oncotelic Therapeutics, Inc. annual Return On Equity for 2022 was 27.6 %.
  • Oncotelic Therapeutics, Inc. annual Return On Equity for 2021 was -101 %, a 57.9% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -58.5 -86.1 -312% Jan 1, 2023 Dec 31, 2023
2022 27.6 +129 Jan 1, 2022 Dec 31, 2022
2021 -101 -37.1 -57.9% Jan 1, 2021 Dec 31, 2021
2020 -64.2 +24.9 +28% Jan 1, 2020 Dec 31, 2020
2019 -89.1 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.